Skip to main content
    G

    GeoVax Labs Inc (GOVX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $2.02
    +0.32 (+18.48%)

    Market Cap: $928,290

    Last updated: Nov 17, 2026 at 11:04 AM ET

    GeoVax Labs Inc (GOVX) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect GeoVax Labs (GOVX) to earn -$123.36 per share in the fiscal year ending Dec 31, 2026. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$68.52.

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus shows a smaller loss.

    Fiscal year ending Dec 31, 2026
    -$123.36
    EPS consensus
    Fiscal year ending Dec 31, 2027
    -$68.52
    EPS consensus
    Next report
    Apr 13, 2027
    Estimated

    EPS range

    Fiscal year endingEPS consensusEPS rangeEPS analysts
    Dec 31, 2026-$123.36-$123.36 to -$123.361
    Dec 31, 2027-$68.52-$73.68 to -$63.362

    Quarterly Estimates

    Quarter endingEPS consensusEPS rangeEPS analysts
    Dec 31, 2026-$29.38N/A3

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has improved from -$208.68.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026-$123.36-$123.36-$123.36-$208.68-$208.68N/A
    Fiscal year ending Dec 31, 2027-$68.52-$68.52-$68.52-$73.68-$73.68N/A

    Frequently Asked Questions About GOVX

    What is the GOVX stock forecast?

    Consensus analyst estimates put GeoVax Labs's EPS at -$123.36 for the fiscal year ending Dec 31, 2026.

    What EPS do analysts expect from GOVX next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$123.36, with estimates from -$123.36 to -$123.36 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$68.52, with estimates from -$73.68 to -$63.36 from 2 analysts.

    How many analysts cover GOVX?

    1 analyst estimates EPS for GeoVax Labs for the fiscal year ending Dec 31, 2026.